ID   NSMA_RAT                Reviewed;         422 AA.
AC   Q9ET64; Q5BKB2;
DT   11-FEB-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-MAR-2001, sequence version 1.
DT   29-MAY-2024, entry version 143.
DE   RecName: Full=Sphingomyelin phosphodiesterase 2;
DE            EC=3.1.4.12;
DE   AltName: Full=Lyso-platelet-activating factor-phospholipase C;
DE            Short=Lyso-PAF-PLC;
DE   AltName: Full=Neutral sphingomyelinase;
DE            Short=N-SMase;
DE            Short=nSMase;
GN   Name=Smpd2;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, AND MUTAGENESIS.
RC   STRAIN=Sprague-Dawley; TISSUE=Liver;
RX   PubMed=10832103; DOI=10.1016/s1388-1981(00)00059-7;
RA   Mizutani Y., Tamiya-Koizumi K., Irie F., Hirabayashi Y., Miwa M.,
RA   Yoshida S.;
RT   "Cloning and expression of rat neutral sphingomyelinase: enzymological
RT   characterization and identification of essential histidine residues.";
RL   Biochim. Biophys. Acta 1485:236-246(2000).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   TISSUE=Spleen;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
CC   -!- FUNCTION: Catalyzes the hydrolysis of sphingomyelin to form ceramide
CC       and phosphocholine. Ceramide mediates numerous cellular functions, such
CC       as apoptosis and growth arrest, and is capable of regulating these 2
CC       cellular events independently. Also hydrolyzes
CC       sphingosylphosphocholine. Hydrolyze 1-acyl-2-lyso-sn-glycero-3-
CC       phosphocholine (lyso-PC) and 1-O-alkyl-2-lyso-sn-glycero-3-
CC       phosphocholine (lyso-platelet-activating factor).
CC       {ECO:0000250|UniProtKB:O60906}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a sphingomyelin + H2O = an N-acylsphing-4-enine + H(+) +
CC         phosphocholine; Xref=Rhea:RHEA:19253, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:17636, ChEBI:CHEBI:52639,
CC         ChEBI:CHEBI:295975; EC=3.1.4.12;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-octadecyl-sn-glycero-3-phosphocholine + H2O = 1-O-
CC         octadecyl-sn-glycerol + H(+) + phosphocholine; Xref=Rhea:RHEA:39923,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:74001,
CC         ChEBI:CHEBI:75216, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:39924;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=an N-(acyl)-sphingosylphosphocholine + H2O = an N-acyl-
CC         sphingoid base + H(+) + phosphocholine; Xref=Rhea:RHEA:45300,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:64583,
CC         ChEBI:CHEBI:83273, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45301;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-hexadecanoyl-sn-glycero-3-phosphocholine + H2O = 1-
CC         hexadecanoyl-sn-glycerol + H(+) + phosphocholine;
CC         Xref=Rhea:RHEA:41119, ChEBI:CHEBI:15377, ChEBI:CHEBI:15378,
CC         ChEBI:CHEBI:72998, ChEBI:CHEBI:75542, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:41120;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=a sphingosylphosphocholine + H2O = a sphingoid base + H(+) +
CC         phosphocholine; Xref=Rhea:RHEA:45296, ChEBI:CHEBI:15377,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:84410, ChEBI:CHEBI:85171,
CC         ChEBI:CHEBI:295975; Evidence={ECO:0000250|UniProtKB:O60906};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:45297;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=1-O-hexadecyl-sn-glycero-3-phosphocholine + H2O = 1-O-
CC         hexadecyl-sn-glycerol + H(+) + phosphocholine; Xref=Rhea:RHEA:36087,
CC         ChEBI:CHEBI:15377, ChEBI:CHEBI:15378, ChEBI:CHEBI:34115,
CC         ChEBI:CHEBI:64496, ChEBI:CHEBI:295975;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:36088;
CC         Evidence={ECO:0000250|UniProtKB:O60906};
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- PATHWAY: Lipid metabolism; sphingolipid metabolism.
CC       {ECO:0000250|UniProtKB:O60906}.
CC   -!- SUBCELLULAR LOCATION: Membrane; Multi-pass membrane protein.
CC   -!- SIMILARITY: Belongs to the neutral sphingomyelinase family.
CC       {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AB047002; BAB08219.1; -; mRNA.
DR   EMBL; BC091139; AAH91139.1; -; mRNA.
DR   RefSeq; NP_112650.1; NM_031360.2.
DR   AlphaFoldDB; Q9ET64; -.
DR   SMR; Q9ET64; -.
DR   STRING; 10116.ENSRNOP00000000336; -.
DR   BindingDB; Q9ET64; -.
DR   ChEMBL; CHEMBL3528; -.
DR   PhosphoSitePlus; Q9ET64; -.
DR   PaxDb; 10116-ENSRNOP00000000336; -.
DR   Ensembl; ENSRNOT00000000336.6; ENSRNOP00000000336.3; ENSRNOG00000000306.6.
DR   Ensembl; ENSRNOT00055001188; ENSRNOP00055000943; ENSRNOG00055000696.
DR   Ensembl; ENSRNOT00060011719; ENSRNOP00060008821; ENSRNOG00060007132.
DR   Ensembl; ENSRNOT00065013572; ENSRNOP00065010073; ENSRNOG00065008547.
DR   GeneID; 83537; -.
DR   KEGG; rno:83537; -.
DR   AGR; RGD:619753; -.
DR   CTD; 6610; -.
DR   RGD; 619753; Smpd2.
DR   eggNOG; KOG3873; Eukaryota.
DR   GeneTree; ENSGT00390000009166; -.
DR   HOGENOM; CLU_034001_4_0_1; -.
DR   InParanoid; Q9ET64; -.
DR   OrthoDB; 50235at2759; -.
DR   PhylomeDB; Q9ET64; -.
DR   TreeFam; TF313899; -.
DR   BRENDA; 3.1.4.12; 5301.
DR   Reactome; R-RNO-5626978; TNFR1-mediated ceramide production.
DR   Reactome; R-RNO-9840310; Glycosphingolipid catabolism.
DR   SABIO-RK; Q9ET64; -.
DR   UniPathway; UPA00222; -.
DR   PRO; PR:Q9ET64; -.
DR   Proteomes; UP000002494; Chromosome 20.
DR   Bgee; ENSRNOG00000000306; Expressed in jejunum and 20 other cell types or tissues.
DR   GO; GO:0005901; C:caveola; IDA:RGD.
DR   GO; GO:0071944; C:cell periphery; IBA:GO_Central.
DR   GO; GO:0005783; C:endoplasmic reticulum; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; ISO:RGD.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008081; F:phosphoric diester hydrolase activity; ISO:RGD.
DR   GO; GO:0004767; F:sphingomyelin phosphodiesterase activity; IDA:RGD.
DR   GO; GO:0046513; P:ceramide biosynthetic process; IDA:RGD.
DR   GO; GO:0006672; P:ceramide metabolic process; ISO:RGD.
DR   GO; GO:0035556; P:intracellular signal transduction; IMP:RGD.
DR   GO; GO:0009612; P:response to mechanical stimulus; IMP:RGD.
DR   GO; GO:0030149; P:sphingolipid catabolic process; IBA:GO_Central.
DR   GO; GO:0006685; P:sphingomyelin catabolic process; ISO:RGD.
DR   GO; GO:0006684; P:sphingomyelin metabolic process; IBA:GO_Central.
DR   Gene3D; 3.60.10.10; Endonuclease/exonuclease/phosphatase; 1.
DR   InterPro; IPR036691; Endo/exonu/phosph_ase_sf.
DR   InterPro; IPR005135; Endo/exonuclease/phosphatase.
DR   InterPro; IPR038772; Sph/SMPD2-like.
DR   PANTHER; PTHR16320:SF1; ENDONUCLEASE_EXONUCLEASE_PHOSPHATASE FAMILY PROTEIN (AFU_ORTHOLOGUE AFUA_1G01540); 1.
DR   PANTHER; PTHR16320; SPHINGOMYELINASE FAMILY MEMBER; 1.
DR   Pfam; PF03372; Exo_endo_phos; 1.
DR   SUPFAM; SSF56219; DNase I-like; 1.
PE   1: Evidence at protein level;
KW   Hydrolase; Lipid metabolism; Magnesium; Membrane; Metal-binding;
KW   Reference proteome; Sphingolipid metabolism; Transmembrane;
KW   Transmembrane helix.
FT   CHAIN           1..422
FT                   /note="Sphingomyelin phosphodiesterase 2"
FT                   /id="PRO_0000075688"
FT   TRANSMEM        325..345
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   TRANSMEM        354..374
FT                   /note="Helical"
FT                   /evidence="ECO:0000255"
FT   REGION          397..422
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   COMPBIAS        408..422
FT                   /note="Basic and acidic residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   ACT_SITE        272
FT                   /note="Proton acceptor"
FT                   /evidence="ECO:0000305"
FT   BINDING         49
FT                   /ligand="Mg(2+)"
FT                   /ligand_id="ChEBI:CHEBI:18420"
FT                   /evidence="ECO:0000250"
FT   SITE            180
FT                   /note="Important for substrate recognition"
FT                   /evidence="ECO:0000250"
FT   MUTAGEN         136
FT                   /note="H->A: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10832103"
FT   MUTAGEN         151
FT                   /note="H->A: Reduced activity."
FT                   /evidence="ECO:0000269|PubMed:10832103"
FT   MUTAGEN         151
FT                   /note="H->Y: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10832103"
FT   MUTAGEN         272
FT                   /note="H->A: Complete loss of activity."
FT                   /evidence="ECO:0000269|PubMed:10832103"
SQ   SEQUENCE   422 AA;  47645 MW;  109A5133A056AAF1 CRC64;
     MKHNFSLRLR VFNLNCWDIP YLSKHRADRM KRLGDFLNLE SFDLALLEEV WSEQDFQYLK
     QKLSLTYPDA HYFRSGIIGS GLCVFSRHPI QEIVQHVYTL NGYPYKFYHG DWFCGKAVGL
     LVLHLSGLVL NAYVTHLHAE YSRQKDIYFA HRVAQAWELA QFIHHTSKKA NVVLLCGDLN
     MHPKDLGCCL LKEWTGLRDA FVETEDFKGS EDGCTMVPKN CYVSQQDLGP FPFGVRIDYV
     LYKAVSGFHI CCKTLKTTTG CDPHNGTPFS DHEALMATLC VKHSPPQEDP CSAHGSAERS
     ALISALREAR TELGRGIAQA RWWAALFGYV MILGLSLLVL LCVLAAGEEA REVAIMLWTP
     SVGLVLGAGA VYLFHKQEAK SLCRAQAEIQ HVLTRTTETQ DLGSEPHPTH CRQQEADRAE
     EK
//
